Wanglong Chu

机构：Harbin Electric Corporation (China), Beike Biotechnology (China) · ORCID：0000-0001-6177-4323

发表论文 6 篇 · 总被引 29 次 · h-index 2

代表论文

A GMP-compliant manufacturing method for Wharton’s jelly-derived mesenchymal stromal cells (2024 · Stem Cell Research & Therapy · 被引 18)
Challenges of Cell Counting in Cell Therapy Products (2024 · Cell Transplantation · 被引 10)
Development of a GMP-Compliant Separation Method for Isolating Wharton's Jelly Derived Mesenchymal Stromal Cells from the Umbilical Cord (2023 · Research Square · 被引 1)
Extracellular Vesicles for Therapeutic Applications: A Translational Framework Integrating Sources, Administration Routes, Indications, Quality Control, and Regulatory Systems (2026 · International Journal of Nanomedicine)
Deep learning-based in silico labeling for analyzing morphological features of MSCs to predict immunomodulatory capacity (2026 · Communications Biology)
Optimization of Culture Media for Human Umbilical Cord‐Derived Mesenchymal Stem Cell Production (2025 · Stem Cells International)